Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Gross Profit (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Gross Profit for 3 consecutive years, with $900000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Gross Profit fell 83.93% to $900000.0 in Q1 2022 year-over-year; TTM through Dec 2022 was $900000.0, a 87.84% decrease, with the full-year FY2022 number at $900000.0, down 87.84% from a year prior.
  • Gross Profit was $900000.0 for Q1 2022 at SELLAS Life Sciences, down from $1.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $5.6 million in Q1 2021 to a low of $900000.0 in Q1 2022.
  • A 3-year average of $2.6 million and a median of $1.8 million in 2020 define the central range for Gross Profit.
  • Biggest YoY gain for Gross Profit was 83.93% in 2022; the steepest drop was 83.93% in 2022.
  • SELLAS Life Sciences' Gross Profit stood at $1.9 million in 2020, then decreased by 5.26% to $1.8 million in 2021, then plummeted by 50.0% to $900000.0 in 2022.
  • Per Business Quant, the three most recent readings for SLS's Gross Profit are $900000.0 (Q1 2022), $1.8 million (Q2 2021), and $5.6 million (Q1 2021).